Case Study - Laki K
Laki's key disease markers have seen a 60-80% reduction through Terry's treatment methods
The Patient
Laki K is a 58 year old male who was diagnosed with smoldering myeloma in 2009 at the age of 47. He entered our curcumin study in 2010. When Laki first entered the study, his paraprotein level was 28.5 grams per litre and his free light chain ratio was 26.77. These are two of the key disease markers for patients with smoldering myeloma.
Treatement & Results
Since 2010 Laki has been taking curcumin daily and his disease markers have shown remarkable improvement over the years. His paraprotein level as of July 2019 is 11 grams per litre – a 61% reduction in paraprotein over a 10 year period. His free light chain ratio as of January 2019 is 5.6 - a 79% reduction over a 10 year period and closer to the normal range of 0.3-1.7. Other markers of disease progression have also improved.
What it Means for Laki
For patients like Laki (with SMM), there is a 50% chance that the disease would have progressed to Multiple Myloma - a very aggressive type of cancer - within 5 years. However, with circumin intervention not only has Laki not progressed after 10 years, but his disease markers have actually improved.
Below are charts of Laki's paraprotein level over a 10 year period: